Careers
|
Partnerships
|
Contact
|
Login
Response Biomedical logo

RAMP® 200

Discover Easy

The RAMP 200 is the only rapid, quantitative, self-calibrating platform in acute care testing. Experience faster results and less stress with the RAMP 200.

Advantages

Test Module
Control Module

EASY TO USE

  • No set-up or installation
  • No sample centrifugation
  • Easy workflow

INTUITIVE

  • Bright LCD touchscreen
  • Multi-language capability
  • Plug and play analyser

COMPLIANT

  • Security features
  • Operator lockout
  • LQC lockout

EFFICIENT

  • LIS connectivity
  • Run up to 6 different tests in parallel
  • Self-calibrating

HIGH QUALITY

  • Built in QC
  • Accurate results in ~15 min
  • No maintenance required

Parallel Testing
in Minutes

The RAMP 200 revolutionizes acute care testing with its innovative design and exceptional performance by offering lab-quality results in ~15 minutes. Our customers love the simplicity of the RAMP 200, coupled with its adaptability and flexibility to test 2, 4, or up to 6 samples in parallel. The RAMP 200’s modular design allows our customers to choose the right configuration to fulfill their testing needs.
ResponseBio-200-D
2 Test Ports
6 Test Ports
RAMP 200 point-of-care analyzer
4 Test Ports
RAMP 200 point-of-care testing analyzer
6 Test Ports

3 Easy Steps

The RAMP 200 takes the complexity out of acute care diagnostic testing
STEP 1
Prepare and Add Sample
STEP 2
Insert Cartridge
STEP 3
Read Results

Accessories

BARCODE SCANNER

Connects to the RAMP 200 via USB. Features omni-directional, hands-free barcode scanning for both operator and patient sample IDs.

RAMP 200 PRINTER

This compact, portable thermal printer features an easy-to-open paper system offering a cost-effective solution.

Contact Our Specialists

24 hour Technical Support available to all RAMP Customers

Faster

Improves turnaround time
for faster triage

Accurate

Provides high quality results
with built in QC

Reliable

Enables clinicians to make
informed decisions
©2025 Response Biomedical. All Rights reserved

You will be able to participate in this research study if you are:

  • 18 years of age or older.
  • In good health.
  • Willing to voluntarily agree to sign the consent form.

You will not be able to participate in this research study if:

  • You are considered/consider yourself to be a vulnerable subject (e.g., nursing home residents, institutionalized persons, pregnant and nursing women, children under the age of 19, prisoners, or persons with decisional incapacity).
  • You are currently diagnosed with, or have a history of, underlying major medical conditions (for example: heart disease, hypertension, stroke, renal disease, diabetes and bleeding disorders).
  • You are actively in hemodialysis treatment.
  • You have been told that you have HIV, chronic active hepatitis B, or chronic, active hepatitis C.
  • You have been hospitalized (for more than 24 hours) in the past three months.
  • You are actively receiving treatment or monitoring for certain cancers (excluding non-melanoma skin cancers and localized prostate cancer not requiring systemic therapy).
  • You are already enrolled in this study.
  • You are unable and/or unwilling to provide informed consent.
If you are interested in participating in this study, you can schedule a time to virtually meet with the clinical team at Response Biomedical. During your online meeting, Response Biomedical will send you a self-assessment questionnaire via DocuSign to determine eligibility. If you are eligbile to participate, a team member will explain the study in detail, review the consent form with you, and send the consent form to you for electronic signature. Once you have signed the consent form, the study staff will arrange an appointment for you at a nearby LifeLabs location.

To participate in this study at a LifeLabs location, you will need to be able to print a paper copy of the requisition to take with you to your appointment. If you do not have access to a printer but would still like to participate, you can book an appointment at the Response Biomedical location or attend a community collection event.
At your LifeLabs appointment, a trained LifeLabs professional will collect two (2) 4 mL tubes of whole blood—approximately two teaspoons.
After collection, your blood sample will be sent to Response Biomedical, where a trained operator will use it to perform the RAMP® hs-TnI test.

Book A Demo

"*" indicates required fields

Name*

Meet Us at the Event

"*" indicates required fields

Name*

Technical Support

"*" indicates required fields

Name*

Get A Quote

"*" indicates required fields

Name*

Partnership

"*" indicates required fields

Name*

You will be able to participate in this research study if you are:

  • 18 years of age or older.
  • In good health.
  • Willing to voluntarily agree to sign the consent form.

You will not be able to participate in this research study if:

  • You are considered/consider yourself to be a vulnerable subject (e.g., nursing home residents, institutionalized persons, pregnant and nursing women, children under the age of 19, prisoners, or persons with decisional incapacity).
  • You are currently diagnosed with, or have a history of, underlying major medical conditions (for example: heart disease, hypertension, stroke, renal disease, diabetes and bleeding disorders).
  • You are actively in hemodialysis treatment.
  • You have been told that you have HIV, chronic active hepatitis B, or chronic, active hepatitis C.
  • You have been hospitalized (for more than 24 hours) in the past three months.
  • You are actively receiving treatment or monitoring for certain cancers (excluding non-melanoma skin cancers and localized prostate cancer not requiring systemic therapy).
  • You are already enrolled in this study.
  • You are unable and/or unwilling to provide informed consent.
If you agree to take part in this study, study staff will discuss a consent form with you. After you sign the consent form, a phlebotomist will collect a blood sample from you. This will include two (2) 4mL tubes worth of whole blood, which is slightly less than 2 teaspoons. Once the blood has been collected, a trained operator will use your blood sample to perform the RAMP® hs-TnI test. The entire visit should last around 30 minutes.